===
Kuros Biosciences AG / Key word(s): Annual Results
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update

2024-03-08 / 07:00 CET/CEST  
-    Company to host conference call and webcast on March 13, 2024, at 3pm CET/10am US EST 

Schlieren (Zurich), Switzerland, March 8, 2024 - Kuros Biosciences ("Kuros" or "the Company"), a leader in
next-generation bone graft technologies, today announced that it will report its full-year financial results and
provide a corporate update on its business on March 13, 2024. Following the announcement, the company will host a
video conference call at 3pm CET/10am US EST to discuss the results.
To register for the video call, click here.
For further information, please contact:

Kuros Biosciences AG          LifeSci Advisors 
Daniel Geiger                 Sandya von der Weid 
Chief Financial Officer       Investors 
t: +41 44 733 47 47           t: +41 78 680 0538 

e: daniel.geiger@kurosbio.com e: svonderweid@lifesciadvisors.com
===
About Kuros Biosciences Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic fusion technologies. With locations in the United States, Switzerland and the Netherlands, the company is listed on the SIX Swiss Exchange. The company's first commercial product, MagnetOsTM, is a unique advanced bone graft that has already been used across three continents and in 25,000 fusion surgeries. For more information on the company, its products and pipeline, visit kurosbio.com.

-----------------------------------------------------------------------------------------------------------------------

End of Media Release

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      Kuros Biosciences AG 

Wagistrasse 25
8952 Schlieren
Switzerland

Phone:        +41 44 733 4747 
Fax:          +41 44 733 4740 
E-mail:       info@kurosbio.com 
Internet:     www.kurosbio.com 
ISIN:         CH0325814116 
Valor:        32581411 
Listed:       SIX Swiss Exchange 
EQS News ID:  1854131 

End of News EQS News Service
===
1854131 2024-03-08 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1854131&application_name=news

END) Dow Jones Newswires

March 08, 2024 01:00 ET (06:00 GMT)